연구성과로 돌아가기
2021 연구성과별 연구자 정보 (402 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Kim, T. | Kim, T | 2 | Chonnam Natl Univ, Dept Med Sci, Med Sch, Jeollanam Do, South Korea | I-6927-2019 | KIM, JIN | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Kim, S. J. | Kim, SJ | 3 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Shin, H-J | Shin, HJ | 4 | Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Koh, Y. | Koh, Y | 5 | Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Kim, J. S. | Kim, JS | 6 | Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea | 0000-0001-8986-8436 | KIM, JIN SEOK | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Park, J. | Park, J | 7 | Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea | 0009-0005-3186-3591 | Park, Jinny | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Park, G. S. | Park, GS | 8 | Catholic Univ Korea, Coll Med, Dept Pathol, Seoul St Marys Hosp, Seoul, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Kim, W. S. | Kim, WS | 9 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | |||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Moon, J. H. | Moon, JH | 10 | 교신저자 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | ||||
| Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial | Yang, D-H | Yang, DH | 11 | 교신저자 | Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Med Sch, 322 Seoyang Ro, Hwasun 58128, Jeollanam Do, South Korea | jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com; | ||||
| Combined analysis of HPK 3.1 LGADs using a proton beam, beta source, and probe station towards establishing high volume quality control | Heller, R. | Heller, R | 1 | 교신저자 | Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA | I-6605-2012 | Heller, Richard | 0000-0002-7368-6723 | Heller, Ryan | rheller@fnal.gov; |
| Combined analysis of HPK 3.1 LGADs using a proton beam, beta source, and probe station towards establishing high volume quality control | Abreu, A. | Abreu, A | 2 | Univ Kansas, Lawrence, KS 66045 USA | rheller@fnal.gov; | |||||
| Combined analysis of HPK 3.1 LGADs using a proton beam, beta source, and probe station towards establishing high volume quality control | Apresyan, A. | Apresyan, A | 3 | Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA | rheller@fnal.gov; | |||||
| Combined analysis of HPK 3.1 LGADs using a proton beam, beta source, and probe station towards establishing high volume quality control | Arcidiacono, R. | Arcidiacono, R | 4 | Ist Nazl Fis Nucl, Turin, Italy | ABF-3918-2020 | Arcidiacono, Roberta | rheller@fnal.gov; | |||
| Combined analysis of HPK 3.1 LGADs using a proton beam, beta source, and probe station towards establishing high volume quality control | Arcidiacono, R. | Arcidiacono, R | 4 | Univ Piemonte Orientale, Vercelli, Italy | ABF-3918-2020 | Arcidiacono, Roberta | rheller@fnal.gov; |
페이지 이동: